N/A N=299 Health Services Research

Building Recovery By Improving Goals, Habits, and Thoughts

Depression · Substance Use

Bottom Line

View on ClinicalTrials.gov: NCT01191788 ↗

Enrolled (actual)

299

Serious AEs

0.0%

Results posted

Jun 2012

Primary outcome: Primary: Depressive Symptoms as Measured by the Beck Depression Inventory II — 14.83; 21.82 BDI-II score

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Group Cognitive Behavioral Therapy (Behavioral); Group CBT for Depression (Behavioral)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: RAND
Primary completion: Jul 2009

Outcome Measures

Outcome	Result	p-value
PRIMARY Depressive Symptoms as Measured by the Beck Depression Inventory II	14.83; 21.82	—
SECONDARY Mental Health Functioning as Measured by SF-12 MCS.	44.71; 38.44	—

Summary

The investigators will investigate whether group Cognitive Behavioral Therapy (CBT) for depression, with alcohol and other drug (AOD) treatment counselors leading the groups, is effective and cost effective in treating depression. If so, it could substantially increase access to appropriate mental health care. 360 clients with Beck Depression Inventory-II scores > 17 who are being treated in a single public sector AOD treatment organization will receive one of two conditions: (1) usual care residential AOD treatment (UC); (2) usual care AOD residential treatment plus a 16-session course of group CBT delivered by trained AOD counselors (CBT). Data will be analyzed using an intent-to-treat model. The investigators will collect data on the service-level costs and health effects associated with UC and CBT, and will calculate the incremental cost per unit of depression and AOD improvement, compared to UC.

Eligibility Criteria

Inclusion Criteria

present for treatment at one of four participating sites during study period
score BDI>17 at 2-4 weeks post-treatment entry

Exclusion Criteria

cognitive impairment (score of 11 or greater on short Blessed exam)
screen positive for bipolar or schizophrenia
non-English speaker

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01191788). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.